Preoperative Planning With PSMA-PET in Melanoma Surgery Trial

Key facts

Sponsor

Royal Marsden NHS Foundation Trust

Principal Investigator

Myles Smith

Royal Marsden NHS Foundation Trust

Intervention

68Ga-PSMA(drug)

Enrollment

16 target

Eligibility

18 years · MALE

Timeline

2025 – 2025

Study locations (1)

• The Royal Marsden NHS Foundation Trust, London, United Kingdom

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for PLA2G6-associated neurodegeneration

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT07141407
  Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person
  Fred Hutchinson Cancer Center
• RECRUITINGPHASE2NCT07132190
  Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction
  Ayal A. Aizer, MD
• RECRUITINGNANCT07263321
  Improving Treatment for Depression in General Practice Using a Step-by-Step Care Plan.
  Aalborg University Hospital
• RECRUITINGNCT07259408
  Co-creation of Tools for People in Detention With Suicidal Thoughts and/or Behavior
  University Ghent
• RECRUITINGNANCT06713603
  Technology Assisted Motivational Interviewing
  University of California, San Francisco
• ACTIVE NOT RECRUITINGNANCT07112664
  Accuracy of Fully Guided Dental Implant Placement by Experienced and Novice Clinicians Using Different Surgical Guides
  Abdelrahman Khalaf Eldabe
• RECRUITINGNANCT06127784
  Survivorship After HNC: A Randomized Controlled Trial Evaluating Patient Care and Adherence to Follow-up
  Western University, Canada
• ACTIVE NOT RECRUITINGNCT07048639
  Dosimetric Evaluation of Breathing Impact on PTV and Adjacent Organ At Risk in Breast Cancer Radiotherapy
  Superior University

See all trials for PLA2G6-associated neurodegeneration →